SCHEMBL11981743

SCHEMBL11981743

O=CC1CC=C(c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)O1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 19/20 0.62
▸ ERBB2 P04626 15/20 0.61
▸ ABL1 P00519 6/20 0.61
▸ INSR P06213 6/20 0.61
▸ PDGFRB P09619 6/20 0.61
▸ CDK2 P24941 6/20 0.61
▸ PLK1 P53350 5/20 0.61
▸ HDAC1 Q13547 5/20 0.61
▸ HDAC8 Q9BY41 5/20 0.61
▸ HDAC6 Q9UBN7 5/20 0.61
▸ HDAC3 O15379 4/20 0.61
▸ HDAC4 P56524 4/20 0.61
▸ HDAC7 Q8WUI4 4/20 0.61
▸ HDAC2 Q92769 4/20 0.61
▸ HDAC10 Q969S8 4/20 0.61
▸ HDAC11 Q96DB2 4/20 0.61
▸ HDAC9 Q9UKV0 4/20 0.61
▸ HDAC5 Q9UQL6 4/20 0.61
▸ ERBB4 Q15303 2/20 0.60
▸ MEN1 O00255 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4763230 0.85 EGFR (0.62) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL20041998 0.84 EGFR (0.72) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL4090004 0.82 EGFR (0.79) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL3799823 0.81 EGFR (0.78) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL17083347 0.81 EGFR (0.74) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL12795405 0.80 EGFR (0.66) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL29387336 0.80 EGFR (0.79) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL28421233 0.80 EGFR (0.66) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL142106 0.80 EGFR (0.79) EGFRERBB2ABL1INSRPDGFRB
SCHEMBL2256751 0.80 EGFR (0.77) EGFRERBB2ABL1INSRPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2484678-A1 4-(SUBSTITUTED ANILINO)QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS Qilu Pharmaceutical Co., Ltd (CN) 2012-08-08 — — EP disclosed
Send feedback